Blogs and Insights on Neuroscience Research
MAGI 2025
MAGI 2025 is a leading conference that brings together over 700 clinical research professionals dedicated to enhancing the quality, compliance, and efficiency of clinical research. Ashely Mitchell, representing Arizona Neuroscience Research, will share her expertise in clinical research, focusing on innovative strategies to advance neurological studies. Her session aims to provide attendees with practical insights…
Power1 Study Focused on epilepsy, Join Today!
a Now Enrolling Participants! We’re currently enrolling participants for a clinical trial focused on epilepsy. If you or someone you know is interested in learning more about this important opportunity, feel free to reach out. Your participation could make a meaningful impact on medical research. Contact us today to learn more. 480-210-8723 #arizona #neuroscience #research…
Cenobamate as a monotherapy for individuals diagnosed with focal onset seizures
Participate in a Groundbreaking Clinical Trial in Phoenix, Arizona with Arizona Neuroscience Research Are you or a loved one living with epilepsy and looking for new treatment options? Arizona Neuroscience Research in Phoenix, AZ, is conducting a clinical trial for Cenobamate monotherapy, an innovative approach to managing focal onset seizures. This is a unique opportunity…
The Moonstone Study: A New Path for Relapsing Multiple Sclerosis Treatment
01/20/2025 | Arizona Neuroscience Research | Uncategorized What is the Moonstone Study? The Moonstone (Drug: Obexelimab) Study is a groundbreaking clinical trial that aims to assess the safety and effectiveness of obexelimab, an investigational treatment for relapsing multiple sclerosis (RMS). The study provides participants with an opportunity to access an innovative therapy that may help…
The POWER1 Study: Exploring Innovative Solutions for Focal Onset Seizures
The POWER1 Study: Advancing Epilepsy Research with Flexible, Home-Based Participation Focus Keyword: focal onset seizures clinical trial What is the POWER1 Study?The POWER1 Study evaluates a new investigational medication, vormatrigine, for adults with focal onset seizures. Participants can contribute to cutting-edge epilepsy research while potentially gaining access to a promising treatment. Why Join the POWER1…
Explore the SOSTOS Clinical Trial: Advancing MS Treatments in Arizona
Are you living with relapsing-remitting multiple sclerosis (RRMS) and stable on treatment for the past 6 months? The SOSTOS Study is now enrolling participants in Arizona and nearby states to explore whether switching treatments can better protect against underlying nervous system damage in MS patients. Join us at Arizona Neuroscience Research and contribute to cutting-edge…
Join the VISTA Clinical Trial: Advancing MS Treatment Options in Arizona
Are you living with relapsing-remitting multiple sclerosis (RRMS) in Arizona or nearby states? The VISTA Study is now enrolling participants to evaluate an innovative oral therapy, PIPE-307, that may provide new hope for individuals managing RRMS. Conducted in collaboration with Arizona Neuroscience Research, this clinical trial represents a critical step in the fight against MS.…
Advancing MS Treatment: Participate in the REMODEL-2 Clinical Trial in Arizona
Are you living with relapsing multiple sclerosis (RMS) in Arizona or nearby states? Here’s your chance to contribute to a groundbreaking clinical trial that could revolutionize MS treatment. The REMODEL-2 (CLOU064C12302) study, sponsored by Novartis, is now enrolling participants in Arizona and surrounding regions. About the REMODEL-2 Study The REMODEL-2 clinical trial is a Phase…
